Hyzmed

Hyzmed Best Medical Product Supplier

Suction catheter
29/10/2025

Suction catheter

2025 Nobel Medical Prize & T-reg Cell BreakthroughThe 2025 Nobel Prize in Physiology or Medicine honors Mary E. Blenko, ...
27/10/2025

2025 Nobel Medical Prize & T-reg Cell Breakthrough
The 2025 Nobel Prize in Physiology or Medicine honors Mary E. Blenko, Fred Ramsdell, and Shimon Sakaguchi for discovering regulatory T cells (T-reg cells)—"immune sentinels" that stop autoimmune attacks while protecting pathogen/cancer-fighting abilities, solving a key immunology puzzle.
This breakthrough already impacts clinics: A Chinese team used modified T-reg cells plus pancreatic islet transplants to cure 15 Type 1 diabetes patients (with a 3+ year insulin-free record). It also offers hope for organ transplant patients (avoiding lifelong immunosuppressants) and cancer treatment (targeting tumor-hijacked T-reg cells).
Commercially, the global autoimmune therapy market may hit $8.2B by 2030 (China’s segment growing at 16.2% CAGR), aligning with precision medicine trends.
Yet challenges remain: ensuring equitable access in low/middle-income countries, scaling cell manufacturing, and addressing long-term safety. Global collaboration is needed to realize Sakaguchi’s vision of "curable cancer within 20 years."

Disposable infusion pump
28/09/2025

Disposable infusion pump

Three function manual hospital bed A-2-3
24/09/2025

Three function manual hospital bed A-2-3

Sino - British Medical Science and Innovation Summit Promotes Global CollaborationDuring the China International Fair fo...
22/09/2025

Sino - British Medical Science and Innovation Summit Promotes Global Collaboration
During the China International Fair for Trade in Services, the 2025 Capital International Medical Conference, hosted by the Chinese Hospital Association, was held in Beijing. More than 1,500 leaders and experts attended. The BMJ Group co - hosted the Sino - British Medical Science and Innovation Summit, where the "2025 China Hospital Research Impact - Twenty - Year Citation Report in Global Health Policy and Clinical Guidelines" was released. This report, the first of its kind, assesses the citation of Chinese hospital research in international clinical guidelines and health policies from 2005 - 2024, showing China's growing influence in global medical research. The summit also saw experts from China and the UK discuss opportunities and challenges in medical research innovation.

FDA Approves First Treatment for Noncirrhotic NASHOn August 23, 2025, the U.S. Food and Drug Administration (FDA) grante...
25/08/2025

FDA Approves First Treatment for Noncirrhotic NASH
On August 23, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra (resmetirom) , a once-daily oral thyroid hormone receptor-β agonist, marking the first FDA-approved therapy for noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (F2-F3). Developed by Madrigal Pharmaceuticals, Rezdiffra demonstrated significant improvements in liver fibrosis and inflammation across phase II and III trials, including the ongoing MAESTRO-NASH study. This approval addresses a critical unmet need, as NASH affects millions globally and lacks effective treatments.

ENT Diagnostics set
21/08/2025

ENT Diagnostics set

Address

Room 2209-2210, New World Business Center, Min’an Road, Yinzhou District
Ningbo

Telephone

+8613857407522

Website

Alerts

Be the first to know and let us send you an email when Hyzmed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Hyzmed:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category